Postencephalitic Symptoms After Tick Borne Encephalitis

Central European Encephalitis Clinical Trial

Official title:

Postencephalitic Symptoms After Tick Borne Encephalitis

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT00941590
• Other study ID #: POST-KME
• Status: Not yet recruiting
• Phase: N/A
• First received: July 16, 2009
• Last updated: July 16, 2009
• Start date: July 2009

Study information

• Verified date: July 2009
• Source: University Medical Centre Ljubljana
• Contact: Katarina Ogrinc, MD PhD
• Phone: +386 1 522 4217
• Email: katarina.ogrinc1[@]guest.arnes.si
• Is FDA regulated: No
• Health authority: Slovenia: Ethics Committee
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to assess clinical outcome in patients with tick borne encephalitis.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 200
• Est. primary completion date: October 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 15 Years and older

Eligibility

Inclusion Criteria:

• serologically proved tick borne encephalitis in patients > 15 years

Exclusion Criteria:

• pregnancy

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Central European Encephalitis
• Encephalitis
• Encephalitis, Tick-Borne

Locations

Country	Name	City	State
Slovenia	UMC Ljubljana, Department of Infectious Diseases	Ljubljana

Sponsors (1)

Lead Sponsor	Collaborator
University Medical Centre Ljubljana

Country where clinical trial is conducted

Slovenia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Objective sequelae and subjective symptoms in patients after tick borne encephalitis.		1 year follow-up.	No
Secondary	Comparison of subjective symptoms between patients after tick borne encephalitis and control subjects without a history of tick borne encephalitis.		1 year follow-up.	No